Market Overview:
The global haemostasis devices market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of cardiovascular diseases, technological advancements in haemostasis devices, and rising demand for minimally invasive procedures. Based on type, the global haemostasis devices market is segmented into vascular closure devices (VCD) and compression devices. The VCD segment is expected to grow at a higher CAGR than the compression device segment during the forecast period. This growth can be attributed to the increasing use of VCDs in minimally invasive procedures and their ability to provide quick and effective hemostasis. Based on application, the global haemostasis devices market is divided into hospitals, clinics, and others (including research institutes and academic centres).
Product Definition:
Haemostasis Devices are tools used to help control bleeding. This may include devices to apply pressure, clamps, or bandages.
Vascular Closure Devices (VCD):
Vascular closure devices (VCD) market is expected to grow at a lucrative rate during the forecast period. The growth of this market can be attributed to factors such as increasing prevalence of vascular diseases, rising geriatric population base and growing demand for minimally invasive surgeries. VCDs are used in various vascular procedures such as endovascular aneurysm repair, carotid artery surgery, peripheral artery surgery and others.
Compression Device:
A compression device is a medical device used to reduce the blood flow and pressure in order to help the body's natural clotting process. It works by applying pressure on a specific part of the body, which helps it recover from bleeding more quickly. The most common places where these are used include legs, arms, pelvis or lower abdomen during surgery or injury and feet after an accident or trauma.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and other healthcare facilities. The hospitals segment dominated the global haemostasis devices market in 2017 owing to increasing prevalence of chronic diseases such as cardiovascular diseases (CVDs), cancer and diabetes which increase the number of surgeries and emergency department visits. According to a study published by NCBI in 2018, it was estimated that around 1 in every 3 deaths occur due to CVDs worldwide. Thus, rising incidence of CVDs increases demand for effective treatment options leading to increased usage of compression devices at hospital settings.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high disposable income, and favorable reimbursement policies. The region is expected to maintain its dominance over the forecast period due to increasing R&D investments by major companies and rising incidences of CVDs & hypertension.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving economic conditions in emerging countries such as India & China. In addition, growing medical tourism industry in these countries can also be attributed for rapid growth of this regional market. For instance, as per a study published by International Society for Medical Tourism (ISMT), India generated USD X billion revenue from medical tourism in 2016 and emerged as one of top five destinations worldwide with Brazil/Brazilia being another popular destination within Asia Pacific region itself.
Growth Factors:
- Increasing incidence of bleeding disorders: The global haemostasis devices market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing incidence of bleeding disorders such as hemophilia, von Willebrand disease, and others.
- Technological advancements: The development of novel haemostasis devices with enhanced features is expected to drive the growth of the market during the forecast period. For instance, in January 2017, Haemonetics Corporation launched its new product – Cell Saver FX – which helps in autologous blood transfusion for patients undergoing cardiac surgery. This product has been designed to improve patient outcomes by reducing complications and improving safety.
- Rising demand for minimally invasive procedures: The preference for minimally invasive procedures over traditional open surgeries is growing across the world due to several advantages such as shorter hospital stays, reduced pain and scarring, and faster recovery times offered by these procedures. This is likely to boost demand for haemostasis devices in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Haemostasis Devices Market Research Report
By Type
Vascular Closure Devices (VCD), Compression Device
By Application
Hospitals, Clinics, Others
By Companies
Abbott, Cardinal Health, Medline Industries, Olympus, Merit Medical, Cura Medical, Terumo, Teleflex, Argon Medical Devices, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Haemostasis Devices Market Report Segments:
The global Haemostasis Devices market is segmented on the basis of:
Types
Vascular Closure Devices (VCD), Compression Device
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Cardinal Health
- Medline Industries
- Olympus
- Merit Medical
- Cura Medical
- Terumo
- Teleflex
- Argon Medical Devices
- Abbott
Highlights of The Haemostasis Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vascular Closure Devices (VCD)
- Compression Device
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Haemostasis Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Haemostasis devices are medical devices that help to stop bleeding. They can be used in a number of different ways, including using pressure to close off blood vessels, using clips or ties to hold tissues in place, and injecting substances into the blood vessel walls to prevent them from closing.
Some of the major companies in the haemostasis devices market are Abbott, Cardinal Health, Medline Industries, Olympus, Merit Medical, Cura Medical, Terumo, Teleflex, Argon Medical Devices, Abbott.
The haemostasis devices market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Haemostasis Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Haemostasis Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Haemostasis Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Haemostasis Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Haemostasis Devices Market Size & Forecast, 2018-2028
4.5.1 Haemostasis Devices Market Size and Y-o-Y Growth
4.5.2 Haemostasis Devices Market Absolute $ Opportunity
Chapter 5 Global Haemostasis Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Haemostasis Devices Market Size Forecast by Type
5.2.1 Vascular Closure Devices (VCD)
5.2.2 Compression Device
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Haemostasis Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Haemostasis Devices Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Haemostasis Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Haemostasis Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Haemostasis Devices Analysis and Forecast
9.1 Introduction
9.2 North America Haemostasis Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Haemostasis Devices Market Size Forecast by Type
9.6.1 Vascular Closure Devices (VCD)
9.6.2 Compression Device
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Haemostasis Devices Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Haemostasis Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Haemostasis Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Haemostasis Devices Market Size Forecast by Type
10.6.1 Vascular Closure Devices (VCD)
10.6.2 Compression Device
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Haemostasis Devices Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Haemostasis Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Haemostasis Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Haemostasis Devices Market Size Forecast by Type
11.6.1 Vascular Closure Devices (VCD)
11.6.2 Compression Device
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Haemostasis Devices Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Haemostasis Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Haemostasis Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Haemostasis Devices Market Size Forecast by Type
12.6.1 Vascular Closure Devices (VCD)
12.6.2 Compression Device
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Haemostasis Devices Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Haemostasis Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Haemostasis Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Haemostasis Devices Market Size Forecast by Type
13.6.1 Vascular Closure Devices (VCD)
13.6.2 Compression Device
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Haemostasis Devices Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Haemostasis Devices Market: Competitive Dashboard
14.2 Global Haemostasis Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Cardinal Health
14.3.3 Medline Industries
14.3.4 Olympus
14.3.5 Merit Medical
14.3.6 Cura Medical
14.3.7 Terumo
14.3.8 Teleflex
14.3.9 Argon Medical Devices
14.3.10 Abbott
